171 related articles for article (PubMed ID: 9517427)
41. Modulation of the NMDA receptor by D-serine in the cortex and the spinal cord, in vitro.
Brugger F; Wicki U; Nassenstein-Elton D; Fagg GE; Olpe HR; Pozza MF
Eur J Pharmacol; 1990 Nov; 191(1):29-38. PubMed ID: 2151187
[TBL] [Abstract][Full Text] [Related]
42. Sustained exposure to a glycine receptor partial agonist differentially alters NMDA receptor agonist and antagonist potencies in cultured spinal cord neurons.
Lin Y; Fossom LH; Skolnick P; Long JB
Eur J Pharmacol; 1998 Sep; 356(2-3):255-60. PubMed ID: 9774257
[TBL] [Abstract][Full Text] [Related]
43. Failure of glycine site NMDA receptor antagonists to protect against L-2-chloropropionic acid-induced neurotoxicity highlights the uniqueness of cerebellar NMDA receptors.
Widdowson PS; Gyte AJ; Upton R; Wyatt I
Brain Res; 1996 Nov; 738(2):236-42. PubMed ID: 8955518
[TBL] [Abstract][Full Text] [Related]
44. Adaptive changes in the NMDA receptor complex in rat hippocampus after chronic treatment with CGP 39551.
Mennini T; Miari A; Presti ML; Rizzi M; Samanin R; Vezzani A
Eur J Pharmacol; 1994 Dec; 271(1):93-101. PubMed ID: 7698217
[TBL] [Abstract][Full Text] [Related]
45. Contribution of the spinal cord BDNF to the development of neuropathic pain by activation of the NR2B-containing NMDA receptors in rats with spinal nerve ligation.
Geng SJ; Liao FF; Dang WH; Ding X; Liu XD; Cai J; Han JS; Wan Y; Xing GG
Exp Neurol; 2010 Apr; 222(2):256-66. PubMed ID: 20079352
[TBL] [Abstract][Full Text] [Related]
46. Developmental maturation of the N-methyl-D-aspartic acid receptor channel complex in postnatal rat brain.
Sircar R
Int J Dev Neurosci; 2000 Feb; 18(1):121-31. PubMed ID: 10708913
[TBL] [Abstract][Full Text] [Related]
47. Spinal cord NMDA receptors modulate peripheral immune responses and spinal cord c-fos expression after immune challenge in rats subjected to unilateral mononeuropathy.
Herzberg U; Murtaugh MP; Carroll D; Beitz AJ
J Neurosci; 1996 Jan; 16(2):730-43. PubMed ID: 8551356
[TBL] [Abstract][Full Text] [Related]
48. [3H]5,7-dichlorokynurenic acid recognizes two binding sites in rat cerebral cortex membranes.
Mugnaini M; Antolini M; Corsi M; van Amsterdam FT
J Recept Signal Transduct Res; 1998; 18(2-3):91-112. PubMed ID: 9651880
[TBL] [Abstract][Full Text] [Related]
49. Neuroprotective effects of RPR 104632, a novel antagonist at the glycine site of the NMDA receptor, in vitro.
Boireau A; Malgouris C; Burgevin MC; Pény C; Durand G; Bordier F; Meunier M; Miquet JM; Daniel M; Chevet T; Jimonet P; Mignani S; Blanchard JC; Doble A
Eur J Pharmacol; 1996 Apr; 300(3):237-46. PubMed ID: 8739214
[TBL] [Abstract][Full Text] [Related]
50. Brain but not spinal NR2B receptor is responsible for the anti-allodynic effect of an NR2B subunit-selective antagonist CP-101,606 in a rat chronic constriction injury model.
Nakazato E; Kato A; Watanabe S
Pharmacology; 2005 Jan; 73(1):8-14. PubMed ID: 15452358
[TBL] [Abstract][Full Text] [Related]
51. Ketobemidone, methadone and pethidine are non-competitive N-methyl-D-aspartate (NMDA) antagonists in the rat cortex and spinal cord.
Ebert B; Andersen S; Krogsgaard-Larsen P
Neurosci Lett; 1995 Mar; 187(3):165-8. PubMed ID: 7624018
[TBL] [Abstract][Full Text] [Related]
52. The pharmacology of native N-methyl-D-aspartate receptor subtypes: different receptors control the release of different striatal and spinal transmitters.
Nankai M; Klarica M; Fage D; Carter C
Prog Neuropsychopharmacol Biol Psychiatry; 1998 Jan; 22(1):35-64. PubMed ID: 9533166
[TBL] [Abstract][Full Text] [Related]
53. Effects of noncompetitive N-methyl-D-aspartate receptor antagonists on opiate tolerance and physical dependence.
Trujillo KA
Neuropsychopharmacology; 1995 Dec; 13(4):301-7. PubMed ID: 8747754
[TBL] [Abstract][Full Text] [Related]
54. The glycine site of the N-methyl-D-aspartate receptor channel: differences between the binding of HA-966 and of 7-chlorokynurenic acid.
Kloog Y; Lamdani-Itkin H; Sokolovsky M
J Neurochem; 1990 May; 54(5):1576-83. PubMed ID: 1691278
[TBL] [Abstract][Full Text] [Related]
55. N-methyl-D-aspartate receptor binding is altered and seizure potential reduced in pregnant rats.
Standley CA
Brain Res; 1999 Oct; 844(1-2):10-9. PubMed ID: 10536256
[TBL] [Abstract][Full Text] [Related]
56. The antiallodynic effect of NMDA antagonists in neuropathic pain outlasts the duration of the in vivo NMDA antagonism.
Christoph T; Schiene K; Englberger W; Parsons CG; Chizh BA
Neuropharmacology; 2006 Jul; 51(1):12-7. PubMed ID: 16616769
[TBL] [Abstract][Full Text] [Related]
57. No protective effect of the NMDA antagonist memantine in experimental spinal cord injuries.
von Euler M; Li-Li M; Whittemore S; Seiger A; Sundström E
J Neurotrauma; 1997 Jan; 14(1):53-61. PubMed ID: 9048311
[TBL] [Abstract][Full Text] [Related]
58. Pre-emptive dynorphin and N-methyl-D-aspartate glutamate receptor antagonism alters spinal immunocytochemistry but not allodynia following complete peripheral nerve injury.
Wagner R; Deleo JA
Neuroscience; 1996 May; 72(2):527-34. PubMed ID: 8737421
[TBL] [Abstract][Full Text] [Related]
59. Use of subunit-specific antisense oligodeoxynucleotides to define developmental changes in the properties of N-methyl-D-aspartate receptors.
Zhong J; Gribkoff VK; Molinoff PB
Mol Pharmacol; 1996 Sep; 50(3):631-8. PubMed ID: 8794904
[TBL] [Abstract][Full Text] [Related]
60. Role of the spinal cord NR2B-containing NMDA receptors in the development of neuropathic pain.
Qu XX; Cai J; Li MJ; Chi YN; Liao FF; Liu FY; Wan Y; Han JS; Xing GG
Exp Neurol; 2009 Feb; 215(2):298-307. PubMed ID: 19046970
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
